|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
����ø |
|
����ø���Ƽ� |
|
Ƥ������ |
| ��������������� | |
|
������ |
|
�ｨ�� |
| PubMed | |
|
Article by |
|
Article by |
����ø�������Ƽ���Ƥ�����������е�����
������, �ｨ��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
���������ϸ��Ⱦɫ��ĩ�˶��صĵ�����-DNA�ṹ,�ǵ���ϸ�������������ͷֻ��������ӡ�����ø����RNA�͵�������ɵĺ˵�����ת¼ø,��ϸ���������Ͱ����йء��о�����85%��90%������ϸ��������ø����,��������ϸ������ø���,��˶���ø������Ϊ������ϵı�־�Ｐ�������Ƶ��°е㡣Ŀǰ��������̽�ֽ����ƶ���ø�ı����Ϊ�����������Ƶ�һ�ֲ��ԡ�
[2] Nakamura TM, Morin GB, Chapman KB,et al. Telomerase catalytic subunit homologs from fission yeast and human. Science, 1997,277:955-959.
[3] Collins K, Kobayashi R, Greider CW. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell, 1995,81:677-686.
[4] Counter CM, Meyerson M, Eaton EN,et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene, 1998,16:1217-1222.
[5] Znolin Y, Jianfang S, Shan L. Detection of telomerase activity in patients with mycosis fungoides. Chin Med Sci J, 2003,18:124-127.
[6] Chen Z, Smith KJ, Skelton HG 3rd,et al. Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma.Exp Biol Med(Maywood), 2001,226:753-757.
[7] Miracco C, Pacenti L, Santopietro R, et al. Evaluation of telomerase activity in cutaneous melanocytic proliferations. Hum Pathol, 2000,31:1018-1021.
[8] Ramirez RD, D'Atri S, Pagani E, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia, 1999,1:42-49.
[9] Hu S, Chan HL, Chen MC,et al. Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits. J Formos Med Assoc,2002,101:593-597.
[10] Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science, 1995,269:1236-1241.
[11] Norton JC, Piatyszek MA, Wright WE,et al. Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol, 1996,14:615-619.
[12] Glukhov Al, Zimnik OV, Gordeev SA, et al. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. Biochem Biophys Res Commun, 1998, 248:368-371.
[13] Folini M, Colella G, Villa R, et al. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. J Invest Dermatol, 2000,114:259-267.
[14] Zhang X, Mar V, Zhou W,et al. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev, 1999,13:2388-2399.
[15] Strahl C, Blackburn EH. The effects of nucleoside analogs on telomerase and telomeres in Tetrahymena. Nucleic Acids Res, 1994,22:893-900.